Miguel Campos Silva

Miguel Campos Silva has held a variety of roles in the healthcare and life sciences industries. Miguel is currently the Strategy Director at OMass Therapeutics, a position they have held since 2020. Prior to this, they were an Associate Director at Navigant from 2014 to 2020, where they also held the roles of Managing Consultant, Senior Consultant, Consultant, and Life Sciences Consulting Intern. In 2014, they were a Health Economics Intern at OptumInsight. Miguel also held internships at Givaudan in 2012 and 2011, where they worked in the Natural Flavour Ingredients sector. In 2011, they worked for 10 weeks on the biotechnological production of natural aldehydes from glycerol using Lactobacillus reuteri. In 2010, they worked for six weeks looking at the process of enzymatic oxidation of alkenes and alcohols, catalyzed by laccase enzyme/ mediator systems.

Miguel Campos Silva completed their Bachelor of Science (BSc) in Biochemistry from the University of St Andrews in 2013. Prior to that, they attended Zurich International School from 2005 to 2009. In 2014, they completed their MSc International Health Policy (Health Economics) from The London School of Economics and Political Science (LSE).